Page last updated: 2024-08-21

18-hydroxycorticosterone and Breast Cancer

18-hydroxycorticosterone has been researched along with Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braley, LM; Williams, GH1
Demers, LM; Harvey, HA; Lipton, A; Melby, JC; Santen, RJ; Wilson, TE1

Other Studies

2 other study(ies) available for 18-hydroxycorticosterone and Breast Cancer

ArticleYear
The effect of angiotensin II and saralasin on 18-hydroxy-11-deoxycorticosterone production by isolated human adrenal glomerulosa cells.
    The Journal of clinical endocrinology and metabolism, 1979, Volume: 49, Issue:4

    Topics: 18-Hydroxycorticosterone; 18-Hydroxydesoxycorticosterone; Adrenal Glands; Adrenalectomy; Aldosterone; Angiotensin II; Breast Neoplasms; Corticosterone; Desoxycorticosterone; Female; Humans; Saralasin

1979
The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 70, Issue:4

    Topics: 18-Hydroxycorticosterone; Adrenal Cortex; Adrenocorticotropic Hormone; Aged; Aldosterone; Aromatase Inhibitors; Binding Sites; Breast Neoplasms; Chemical Phenomena; Chemistry; Cytochrome P-450 CYP11B2; Cytochrome P-450 Enzyme Inhibitors; Electrolytes; Fadrozole; Female; Humans; Hydrocortisone; Imidazoles; In Vitro Techniques; Mineralocorticoids; Mixed Function Oxygenases; Nitriles

1990